These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 7298116)

  • 1. Effect of prostaglandin inhibition on the hypertensive action of sodium-retaining steroids.
    Martin K; Zipser R; Horton R
    Hypertension; 1981; 3(5):622-8. PubMed ID: 7298116
    [No Abstract]   [Full Text] [Related]  

  • 2. 9-alpha-Fluorocortisol-induced hypertension: a review.
    Whitworth JA; Butkus A; Coghlan JP; Denton DA; Mills EH; Spence CD; Scoggins BA
    J Hypertens; 1986 Apr; 4(2):133-9. PubMed ID: 3519760
    [No Abstract]   [Full Text] [Related]  

  • 3. 19-Hydroxyandrostenedione: evidence for a new class of sodium-retaining and hypertensinogenic steroids.
    Sekihara H
    Endocrinology; 1983 Sep; 113(3):1141-8. PubMed ID: 6347666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Orthostatic hypotension. Treatment with sodium chloride and sodium retaining steroid hormones.
    Shear L
    Arch Intern Med; 1968 Dec; 122(6):467-71. PubMed ID: 5721870
    [No Abstract]   [Full Text] [Related]  

  • 5. The effects of fludrocortisone acetate and deoxycorticosterone acetate on salt appetite in mice.
    Underwood KA; McCutcheon NB; Dudek BC
    Physiol Behav; 1993 Oct; 54(4):671-5. PubMed ID: 8248344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Water and salt loading in adrenalectomised dogs treated with cortexone, aldosterone, and 9alpha-fluorocortisol.
    DETTBARN WD; GROSS F
    Acta Endocrinol (Copenh); 1956 Aug; 22(4):335-70. PubMed ID: 13354226
    [No Abstract]   [Full Text] [Related]  

  • 7. Mineralocorticoid-induced blood pressure, electrolyte, and hormone changes, and reversal with spironolactone, in healthy men.
    Nicholls MG; Ramsay LE; Boddy K; Fraser R; Morton JJ; Robertson JI
    Metabolism; 1979 May; 28(5):584-93. PubMed ID: 449700
    [No Abstract]   [Full Text] [Related]  

  • 8. Proceedings: Kallikrein excretion during the "escape" from the sodium retaining effect of fludrocortisone.
    Edwards OM; Adetuyibi A; Mills IH
    J Endocrinol; 1973 Nov; 59(2):xxxiv. PubMed ID: 4759624
    [No Abstract]   [Full Text] [Related]  

  • 9. Assessment of the mineralocorticoid activity of 18-hydroxy-11-deoxycorticosterone (18-OH-DOC) in the isolated toad bladder.
    Porter GA; Kimsey J
    Endocrinology; 1971 Aug; 89(2):353-7. PubMed ID: 5557989
    [No Abstract]   [Full Text] [Related]  

  • 10. Differential blood pressure and metabolic effects of 9 alpha-fluorocortisol in man.
    Whitworth JA; Saines D; Thatcher R
    Clin Exp Pharmacol Physiol; 1983; 10(3):351-4. PubMed ID: 6354534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms of desoxycorticosterone action. IX. Temporal relationships of polyuria, polydipsia, sodium exchange and hypertension.
    GREEN DM; SAUNDERS FJ; VAN ARMAN CG; CALVIN LD; STURTEVANT FM
    Am J Physiol; 1952 Sep; 170(3):486-97. PubMed ID: 12985921
    [No Abstract]   [Full Text] [Related]  

  • 12. [Comparative effects of DOCA and aldosterone administration on exchangeable sodium and arterial pressure in uninephrectomized rats subjected to a sodium load].
    Zech P; Boissel JP; Bouletreau P
    C R Seances Soc Biol Fil; 1968 Nov; 162(4):926-30. PubMed ID: 4235899
    [No Abstract]   [Full Text] [Related]  

  • 13. Hypertension and disturbances of tissue water, sodium and potassium distribution associated with steroid administration in adrenalectomised rats.
    LEDINGHAM JM
    Clin Sci; 1954 Nov; 13(4):543-53. PubMed ID: 13209839
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of 9-alpha-fluorohydrocortisone on blood pressure, plasma volume, and sodium, potassium and water balance in rats.
    Haack D; Hackenthal E; Homsy E; Möhring B; Möhring J
    Acta Endocrinol (Copenh); 1974 Jul; 76(3):539-55. PubMed ID: 4406912
    [No Abstract]   [Full Text] [Related]  

  • 15. Urinary kallikrein excretion in hypertensive man. Relationships to sodium intake and sodium-retaining steroids.
    Margolius HS; Horwitz D; Pisano JJ; Keiser HR
    Circ Res; 1974 Dec; 35(6):820-5. PubMed ID: 4430079
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of prostaglandin blockade on Na transport by the different segments of human nephron.
    Satta A; Faedda F; Branca GF; Olmeo NA; Soggia G; Bartoli E
    Panminerva Med; 1984; 26(3):149-55. PubMed ID: 6522076
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of aldosterone and other steroids in vivo on rat-kidney cortex. Alterations in translation by isolated ribosomes and in the thiol content of nuclear proteins.
    Trachewsky D; Nandi Majumdar AP; Congote LF
    Eur J Biochem; 1972 Apr; 26(4):543-52. PubMed ID: 5025930
    [No Abstract]   [Full Text] [Related]  

  • 18. Potentiation of the hypertensive effects of desoxycorticosterone acetate by various sodium salts.
    FRIEDMAN SM; FRIEDMAN CL; POLLEY JR
    Am J Physiol; 1948 May; 153(2):226-34. PubMed ID: 18872635
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of fludrocortisone and spironolactone on sodium and potassium losses in secretory diarrhea.
    Wenzl HH; Fine KD; Santa Ana CA; Porter JL; Fordtran JS
    Dig Dis Sci; 1997 Jan; 42(1):119-28. PubMed ID: 9009126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hypertensinogenic steroids].
    Kudo K; Abe K; Yoshinaga K
    Nihon Rinsho; 1984 Nov; 42(11):2547-51. PubMed ID: 6397622
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.